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Objective: Gene therapy is a promising strategy to modify ischemia-
reperfusion injury and rejection after transplantation. We evaluated vari-
ables that may affect ex vivo gene transfer to rat lung isografts. Methods:
Left lungs were harvested and perfused via the pulmonary vein with
chloramphenicol acetyltransferase complementary deoxyribonucleic acid
complexed with cationic liposomes. Several variables were examined: (1)
Influence of temperature: In group I (n 5 4), grafts were stored for 4 hours
at 23° C and transplanted. Chloramphenicol acetyltransferase activity was
assessed on postoperative day 2. In groups II and III (n 5 4), grafts were
stored at 10° and 4° C, respectively. Arterial oxygen tension and inflamma-
tory infiltrate were also determined. (2) Influence of storage time: Grafts
were preserved at 10° C for 1, 2, 3, 4 (n 5 4), and 10 hours (n 5 5).
Chloramphenicol acetyltransferase activity was assessed on postoperative
day 2. (3) Rapidity and duration of transgene expression: Grafts were
preserved at 10° C for 1 hour and then transplanted. Chloramphenicol
acetyltransferase activity was assessed 2, 4, 6, 12, and 24 hours and 2, 7, 14,
21, and 28 days after implantation. Results: Chloramphenicol acetyltrans-
ferase expression was apparently less in lungs transfected at 4° C than in
those transfected at 10° and 23° C. Storage for 1 hour at 10° C was sufficient
to yield significant expression. Increasing the exposure time to 10 hours did
not increase toxicity. There were no differences in arterial oxygen tension
between transfected and nontransfected lungs. Chloramphenicol acetyl-
transferase expression was detected for at least 28 days. Conclusion: Ex vivo
liposome-mediated transfection of lung isografts can be achieved after a
short time of cold storage, with minimal toxicity. (J Thorac Cardiovasc
Surg 1998;115:38-44)
The progress of techniques to introduce exogenousdeoxyribonucleic acid (DNA) into mammalian
somatic cells has opened up the possibility of treat-
ing inherited and acquired diseases at the genetic
level. In lung transplantation, gene therapy may
prove useful to prevent or attenuate complications
such as ischemia-reperfusion injury, rejection, and
infection.
Gene delivery systems play a central role in gene
therapy. Currently used replication-deficient viral
vectors raise problems such as host immune-inflam-
matory responses and oncogenicity.1-4 Transgene
expression is transient and, contrary to liposomal
vectors, a second administration is not effective,
because the newly transduced cells are destroyed by
host immune responses.3 Furthermore, when an
adenovirus vector is delivered to the pulmonary
microvasculature, an unpredictable transduction
pattern is observed.5, 6 We7 have previously reported
the use of a liposomal vector to transfect lung grafts
before harvest (in vivo donor transfection). With
this vector, we observed consistent and homoge-
neous distribution of expression throughout the lung
parenchyma. In addition, the observed toxicity was
minimal and there was no impairment of subsequent
graft function. However, in the in vivo approach,
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transgene expression was not restricted to lungs, but
was also observed in donor hearts. Whether this
would pose a problem in the context of multiple
cadaveric organ retrieval requires additional studies
with functional genes. An ex vivo approach might
circumvent this potential problem.
Recently, ex vivo liposome-mediated gene trans-
fer to rabbit heart allografts has been reported.8
We7 have shown that this vector system is possible in
the setting of lung transplantation, using a rat lung
transplant model and the chloramphenicol acetyl-
transferase (CAT) reporter gene. In the current
study, we specifically aimed to determine (1) the
influence of graft storage temperature on transfec-
tion efficiency, (2) the influence of storage time on
ex vivo transfection efficiency, (3) the rapidity and
duration of transgene expression after graft implan-
tation, (4) whether the ex vivo strategy yields trans-
gene expression restricted to the lung grafts, and (5)
whether transgene expression could occur during
the preservation time.
Materials and methods
Plasmid expression vector. The plasmid pCF1-CAT
(Genzyme Corporation, Framingham, Mass.) consists of
the human cytomegalovirus immediate early gene pro-
moter/enhancer, a hybrid intron, the CAT cDNA, the
bovine growth hormone polyadenylation signal sequence,
and a kanamycin resistance gene and was constructed as
previously described.9
Preparation of cationic lipid:L-dioleoyl phosphatidyl-
ethanolamine (DOPE):DNA complexes. Lipid 67 (Gen-
zyme Corporation) is an amphophile consisting of a
hydrophobic lipid anchor (cholesterol) linked to a sperm-
ine head group in a T-shaped configuration. Lipid 67:
DOPE, in a molar ratio of 1:2, was supplied as dried films
and prepared as previously described.9 Before use, the
films were hydrated with sterile water, treated in a vortex
until opaque, incubated on ice for 10 minutes, and then
treated in a vortex again for 2 minutes. Equal volumes of
lipid 67:DOPE and CAT cDNA were mixed and incu-
bated at room temperature for a minimum of 30 minutes.
Final lipid and DNA concentration were 1 mmol/L and 4
mmol/L, respectively.
Animals. Inbred male Fischer rats weighing 270 to 300
gm (Charles River Laboratories, Wilmington, Mass.) were
used in all experiments. Animals received humane care in
compliance with the “Principles of Laboratory Animal
Care” formulated by the National Society for Medical
Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Labo-
ratory Animal Resources and published by the National
Institutes of Health (NIH Publication No. 85-23, revised
1985).
Rat lung transplantation. An orthotopic left lung rat
transplant model was developed by means of a modifica-
tion of the “cuff” technique.10 In brief, donor lungs were
flushed through the main pulmonary artery with 20 ml of
normal saline solution at 20 cm H2O of pressure. The
heart-lung block was excised with the lungs inflated at
Fig. 1. CAT activity in lung grafts transfected ex vivo and stored for 4 hours at 23°, 10°, and 4° C. CAT
activity in the transplanted left lungs was assessed on postoperative day 2. Each column represents one
animal. The bottom row represents nonacetylated chloramphenicol, the middle row represents monoacety-
lated chloramphenicol, and the top row represents diacetylated chloramphenicol. The top two rows are
observed only when CAT is present. CAT activity was present in both groups stored at low temperatures,
although there was apparently less in the 4° C group than in the 10° C group.
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end-tidal volume and the left pulmonary vein was cannu-
lated with a silicone catheter inserted through the left
atrial appendage. Lipid 67:DOPE:CAT was diluted in 10
ml of saline solution and infused retrogradely over 7 to 10
minutes at 20 cm H2O pressure. The retrograde flush was
used because it is extremely easy to cannulate the vein
through the left atrial appendage and also because distri-
bution of the preservation solution is better when it was
perfused in a retrograde fashion.11 Subsequently, the left
lung was dissected and 14-gauge cuffs were inserted into
the left pulmonary artery, vein, and bronchus. The grafts
were implanted with the use of a cuff technique for all
anastomoses, and recipient animals were allowed to re-
cover from anesthesia.
Experimental design
Influence of storage temperature on ex vivo transfection
efficiency. Left lungs were harvested and divided into
three groups (n 5 4 per group). In group I, lipid 67:
DOPE:CAT cDNA was diluted in 10 ml of normal saline
solution and infused retrogradely into the left lung. Grafts
were stored at 23° C for 4 hours and then implanted. In
groups II and III, grafts underwent the same procedure,
but storage was at 10° and 4° C, respectively. On postop-
erative day 2, left lungs were harvested for CAT assay.
Influence of storage time on ex vivo transfection efficiency.
Left lungs were harvested and divided into four groups
(n 5 4 per group). In group I, lipid 67:DOPE:CAT cDNA
(0.25:0.50:1.0 mol) was infused retrogradely through the
pulmonary vein. Grafts were stored at 10° C for 1 hour
and then transplanted. Recipients were killed on postop-
erative day 2 and transplanted lungs were assessed for
CAT activity. In groups II, III, and IV, lungs were stored
for 2, 3, and 4 hours, respectively, and CAT activity in
transplanted lungs was assessed on postoperative day 2.
Rapidity of transgene expression. Left lungs were har-
vested and lipid 67:DOPE:CAT cDNA (0.25:0.50:1.0 mol)
was infused retrogradely. Grafts were stored at 10° C for 1
hour and divided into six groups (n 5 4 per group). In
group I, grafts were frozen after the 1-hour storage period
and assayed for CAT activity. In groups II, III, IV, V, and
VI, lung grafts were transplanted and recipient animals
were killed 2, 4, 6, 12, and 24 hours later and CAT activity
was determined.
Duration of transgene expression. Lung grafts were in-
fused retrogradely with lipid 67:DOPE:CAT cDNA (0.25:
0.50:1.0 mol), stored at 10° C for 1 hour, and then
transplanted. Recipient animals were killed 2, 7, 14, 21,
and 28 days after transplantation and CAT activity was
assessed (n 5 4 per group).
Extrapulmonary transgene expression. Extrapulmonary
CAT activity was determined in recipient animals that
received lungs transfected for 4 hours at 23° C. Forty-four
hours after transplantation, recipients were killed and
lungs were flushed with normal saline solution. Trans-
planted left lungs, hearts, and livers were snap-frozen in
liquid nitrogen and stored at –80° C until assayed for CAT
activity.
Transgene expression during the preservation time. To
verify whether transgene expression could occur during
the preservation time, before implantation, we infused ex
vivo 660 mg of CAT cDNA complexed to lipid 67 and
diluted in 5 ml of normal saline solution into the harvested
left lung (n 5 5). After 12 hours of exposure at 10° C, the
grafts were frozen and assessed for CAT activity.
CAT activity assay. Transgene expression was detected
by a CAT activity assay by means of thin-layer chroma-
tography as described elsewhere.7, 12 The CAT enzyme
catalyzes the transfer of one or two acetyl groups from
acetyl coenzyme A to chloramphenicol, yielding mono-
acetylated and diacetylated forms of chloramphenicol,
which by thin-layer chromatography are distinct from the
nonacetylated chloramphenicol (Fig. 1). Eukaryotic cells
contain no background of CAT activity, and therefore any
activity detected in lung homogenates comes from the
successfully transferred CAT gene.
Evaluation of pulmonary toxicity. The pulmonary tox-
icity of the liposome-plasmid complex was evaluated by
assessing lung gas exchange and inflammatory infiltrates
(hematoxylin and eosin staining). Additionally, in five
animals, the lung grafts were infused with double the dose
of liposome-DNA complexes previously used, preserved
for 10 hours at 10° C, and then transplanted. To serve as
Fig. 2. CAT activity in lung grafts transfected ex vivo and stored at 10° C for 1 hour, 2 hours, 3 hours, and
4 hours. Storage times as short as 1 hour were sufficient to yield significant transgene expression.
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Fig. 3. Rapidity (A) and duration (B) of transgene expression in the ex vivo setting after storage at 10° C
for 1 hour, transplantation, and assessment for CAT activity at different time points. Transgene expression
became detectable 4 to 6 hours after implantation, and significant levels were observed at least for 28 days.
Each column represents one animal.
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controls, five animals underwent the same procedure but
the grafts were not infused with liposome-CAT cDNA
complexes. This was done to verify whether a longer
exposure time to liposomes could affect the graft function.
Arterial oxygenation was determined as follows. In the
transplant setting, rats were anesthetized with pentobar-
bital (50 mg/kg), systemically heparinized (1000 IU hepa-
rin per kilogram), and subjected to a median sternotomy-
laparotomy. The right pulmonary artery and right main-
stem bronchus were clamped and the left lung was
ventilated (inspired oxygen fraction, 1; tidal volume, 2 ml;
respiratory rate, 80 breaths/min) and perfused for 5
minutes. An arterial blood sample was then obtained from
the abdominal aorta and analyzed for oxygenation. In
normal rats, arterial oxygenation was determined while
both lungs were ventilated for at least 5 minutes with the
use of the same parameters previously described.
Statistical analysis. Data were compared by t test by
means of the software Microsoft Excel for Windows 95,
version 7.0 (Microsoft Corporation, Redmond, Wash.),
when applicable. Data were expressed as mean 6 stan-
dard error, with a p , 0.05 considered statistically signif-
icant.
Results
Eighty-two lung transplants were performed
throughout this study with one operative death
caused by a technical failure. Transgene expression
was observed in all grafts transfected ex vivo.
Influence of storage temperature. Transgene ex-
pression was observed in all grafts transfected at 23°,
10°, and 4° C. CAT activity was less in lungs stored at
4° C than in those stored at 23° and 10° C. Expres-
sion was roughly equivalent in lung grafts stored at
10° and 23° C (Fig. 1).
Influence of storage time. Significant and essen-
tially equivalent CAT activity was observed in grafts
transfected ex vivo and stored at 10° C for 1 or 2
hours before transplantation (Fig. 2). Increasing the
storage time to 3 or 4 hours led to a slight increase
in transgene expression, as shown in Fig. 2.
Rapidity and duration of transgene expression.
Transgene expression was negligible in lung grafts
that were snap-frozen immediately after the 1-hour
storage period and in lungs assessed 2 hours after
transplantation. CAT activity reached significant
levels 4 to 6 hours after reperfusion, peaked at 12
hours, and significant levels were maintained in
most grafts for at least 28 days (Fig. 3, A and B).
Transgene expression during the preservation
time. No CAT activity was detected in any lung
grafts after 12 hours of exposure to the liposome-
CAT cDNA complexes.
Extrapulmonary transgene expression. CAT ac-
tivity, albeit minimal, could be detected in recipient
hearts. On the other hand, no CAT activity was
detected in livers (Fig. 4). When grafts were flushed
with normal saline solution before implantation to
remove the lipid-DNA complex from the lung mi-
crovasculature, no CAT activity was detected in the
recipient hearts.
Fig. 4. Extrapulmonary transgene expression. Lungs were transfected ex vivo, stored for 4 hours at 23° C,
and transplanted. On postoperative day 2 organs were harvested and analyzed for CAT activity. Minimal
levels of CAT activity were observed in recipient hearts. There was detectable CAT activity in recipient
livers. Heart expression could be eliminated by rinsing the lung vasculature before implantation (data not
shown).
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Pulmonary toxicity of lipid 67:DOPE:CAT. No
significant difference in arterial oxygenation was
observed in animals that received grafts transfected
ex vivo for 4 hours at 10° C compared with normal
controls (546 6 17.6 mm Hg vs 523.5 6 18.4 mm Hg
for transfected animals and normal controls, respec-
tively; n 5 5 per group; p 5 0.4, t test : two sample
hours did not affect arterial oxygenation [529 6 31
mm Hg vs 532 6 99 mm Hg for grafts transfected ex
vivo for 10 hours and transplanted and nontrans-
fected assuming equal variances]). In addition, in-
creasing the time of exposure to the liposome-DNA
complexes to 10 grafts preserved at 10° C for 10
hours and transplanted, respectively, p 5 0.97, t test
: two sample assuming unequal variances). Hema-
toxylin and eosin staining demonstrated a minimal
mononuclear cell infiltrate.
Discussion
We7 have recently reported our results with an in
vivo liposome-mediated gene transfer approach, in
which the donor was treated intravenously before
harvest. The objective of that initial study was to
achieve transgene expression at the time of harvest.7
In that setting, we demonstrated that in vivo lipo-
some-mediated gene transfer to rat lung isografts
was efficient, did not interfere with graft function,
and transgene expression was present at the time of
harvest when the liposome-DNA complex was in-
jected at least 2 hours before harvest. Transgene
expression was also high in donor hearts and mini-
mally present in livers and kidneys. Thus complete
target specificity was not achieved with the in vivo
approach, which is important in the setting of mul-
tiple cadaveric organ retrieval.
The ex vivo approach should restrict transgene
expression to the organ of interest. Surprisingly,
when we transfected lung grafts ex vivo, transgene
expression was also detected in recipient hearts,
although this was minimal. Even when minimal
transgene expression occurs, it is important to re-
member that this expression is transient and thus
should not pose a problem. Moreover, other inves-
tigators have shown that liposomes are not toxic to
hearts.13, 14 This heart-based expression could be
eliminated by flushing the grafts before implanta-
tion to remove the remaining liposome-DNA com-
plexes from the pulmonary microvasculature.
In the present study, all lung grafts transfected ex
vivo showed recombinant gene expression as dem-
onstrated by the CAT assay. In this setting, signifi-
cant transgene expression was observed for at least
28 days after infusion of the lipid-DNA complex.
This result differs from that obtained in the in vivo
setting, where transgene expression was minimal on
day 21.7 We speculated that the ex vivo approach
allows a more prolonged and undisturbed contact
between the liposome-DNA complexes and the en-
dothelium, contrary to the in vivo approach, where
the blood flow could be a disturbing factor. This
could account for a better transfection rate with the
ex vivo approach and consequently a more pro-
longed transgene expression.
To be practical, the transfection procedure must
not be a source of injury to the graft. Studies in
healthy human volunteers have shown no acute
adverse effects when liposomes were administered
by aerosol inhalation.15 Canonico and associates16
have demonstrated in rabbits that weekly intrave-
nous or aerosol delivery of cationic liposome-DNA
complexes did not affect lung histology, mechanics,
or oxygenation. In our present study, we observed
minimal lung toxicity from the cationic lipid–DNA
complexes. Graft function was not significantly af-
fected, as demonstrated by normal arterial oxygen-
ation and minimal host inflammatory response. This
is contrary to what has been shown with viral
vectors, which are capable of triggering a significant
host immune-inflammatory response that hampers
transgene expression and leads to low transduction
efficiency if a second administration of the viral
vector-DNA is required. Conversely, the liposomal
vector has been demonstrated to allow sustained
transgene expression when readministered, inas-
much as it does not activate the host immune
system.9, 16
Our study demonstrates that ex vivo liposome-
mediated gene transfer can occur under conditions
that mimic those required clinically, such as cold
storage for short periods of time. This is especially
important in the setting of transplantation, because
it avoids the paradox of increasing storage time and
consequently ischemic time to allow gene transfer to
occur. We have demonstrated that liposome-medi-
ated graft transfection can occur with a storage time
as short as 1 hour and results in CAT activity similar
to that observed in lungs stored for 3 or 4 hours.
Although the chromatographic method for CAT
activity allows visual confirmation of the data, it is
not accurate to quantify this activity because of its
narrow linear range, which is a limitation of the
method in this study.
Further, we observed that when the liposome-DNA
complex remained in the pulmonary microvasculature
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for longer cold storage times (10 hours), no toxicity
was observed, on the basis of arterial oxygenation
measured when ventilating only the transplanted lung.
One would expect that low temperature could affect
gene transfer, because cellular metabolism is signifi-
cantly decreased. Indeed, transgene expression ap-
peared to be less in lungs transfected at 4° C when
compared with those transfected at 10° C. On the
other hand, we cannot assure that this will correspond
to a decrease in functional effect when a functional
gene is used. This remains to be tested with a func-
tional gene. Further, when we doubled the liposome-
CAT cDNA concentration (660 mg of DNA), we did
not observe an increase in toxicity.
In the ex vivo setting, significant transgene expres-
sion was not observed until 4 to 6 hours after implan-
tation. Although this timing of expression should not
pose a problem when the clinical target is allograft
rejection, it may not be the ideal situation for isch-
emia-reperfusion injury, where transgene expression
at the time of implantation would be optimal.
In summary, we have determined the pattern of
transgene expression in the setting of lung trans-
plantation, using an ex vivo approach and a reporter
gene (CAT) complexed to cationic lipids. Our study
demonstrates that ex vivo gene transfer to lung
isografts at low temperature yields consistent and
reproducible transgene expression. In addition, it
shows that transgene expression can be achieved
with short storage times and that transfection does
not interfere with subsequent graft function.
Whether these levels of transgene expression are
sufficient to produce beneficial effects in the graft
will be determined in future studies in which func-
tional genes are used.
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